Baricitinib therapy in COVID-19: A pilot study on safety and clinical impactFabrizio Cantini, Delia Goletti|Journal of Infection|2020Cited by 445
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre studyFabrizio Cantini, Delia Goletti|Journal of Infection|2020Cited by 179
Optimization of the autophagy measurement in a human cell line and primary cells by flow cytometryTonino Alonzi, Delia Goletti|European Journal of Histochemistry|2019Cited by 11